Bioethics News

Gene Therapy in U.S. Is On Track for Approval as Early as Next Year

Spark Therapeutics is within striking distance of a landmark green light from the FDA for its treatment for certain forms of blindness

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.